CAS # 943319-70-8
Targeted TKI Grade (MW 532.56 g/mol)
Ponatinib T315I BCR::ABL Kinase Inhibitor
Ponatinib is a targeted tyrosine kinase inhibitor (C29H27F4N6O) inhibiting ABL/BCR::ABL, including the T315I mutant form in Philadelphia chromosome-positive ALL and Chronic Myeloid Leukemia (CML).
Assay / Purity
≥ 98.5% (C29H27F4N6O)
Physical Appearance
Off-White to Yellow Powder
Documentation
CoA / DMF / GMP
Direct Procurement Quote
Fill details to receive commercial terms and Certificate of Analysis (CoA).
Technical Specifications Summary
Chemical / Product Name
Ponatinib T315I BCR::ABL Kinase Inhibitor
CAS Registry Number
943319-70-8
Standard Grade
Targeted TKI Grade (MW 532.56 g/mol)
Assay / Purity
≥ 98.5% (C29H27F4N6O)
Appearance
Off-White to Yellow Powder
Formulation & Industry Applications
Ph+ ALL Oral Tablets
CML T315I Mutation Regimens
Related Ingredients
Explore complementary ingredients in Oncology APIs Portfolio: